TIANJIN -- Danish pharmaceutical giant Novo Nordisk announced Monday that it will inject an additional 200 million yuan (around $29.4 million) into its production base in North China's Tianjin municipality, expanding drug production and ramping up assembly and manufacturing capacity of its related injection pens.

TIANJIN -- Danish pharmaceutical giant Novo Nordisk announced Monday that it will inject an additional 200 million yuan (around $29.4 million) into its production base in North…

Eighteen months after Novo Nordisk purchased a plant in the | Eighteen months after Novo Nordisk purchased a plant in the Czech Republic from Novavax, the Danish drugmaker said it…